<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863126</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.151</article-id><article-id pub-id-type="other">O0016</article-id><article-id pub-id-type="pii">S0924933824001512</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>Use of Intranasal Oxytocin to Treat Adult Autism Spectrum Disorder: A Randomized Double Blind Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Faraji Niri</surname><given-names>S.</given-names></name><xref rid="aff0053" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0012" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Alaghband-rad</surname><given-names>J.</given-names></name><xref rid="aff0053" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Motamed</surname><given-names>M.</given-names></name><xref rid="aff0053" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hojjati</surname><given-names>S. A.</given-names></name><xref rid="aff0054" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Seyed Alipour</surname><given-names>S.</given-names></name><xref rid="aff0053" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mohebbi</surname><given-names>N.</given-names></name><xref rid="aff0055" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff0053">
<sup>1</sup>Psychiatry, Tehran University of Medical Sciences</aff><aff id="aff0054">
<sup>2</sup>Urology, Shahid Beheshti University of Medical Sciences</aff><aff id="aff0055">
<sup>3</sup>Pharmacology, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic Of</aff><author-notes><corresp id="cor0012"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="126">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S48</fpage><lpage>S49</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824001512a.pdf"/><abstract><sec id="sec0067"><title>Introduction</title><p>Autism Spectrum Disorder (ASD) is characterized by impairments in social interaction and restricted interests. It has been reported that oxytocin may improve processing of social cues and emotions in adults with ASD.</p></sec><sec id="sec0068"><title>Objectives</title><p>The aim of this study was to evaluate the therapeutic effects and safety of intranasal oxytocin in this population.</p></sec><sec id="sec0069"><title>Methods</title><p>Thirty-nine patients with ASD were randomly assigned to two groups: one group received intranasal oxytocin and the other group received a placebo, with 24 units administered every 12 hours for 8 weeks. The patients were evaluated using the Autism Quotient (AQ), Ritvo Autism Asperger Diagnostic Scale &#x02013; Revised (RAADS-R), Social Responsiveness Scale (SRS), Clinical Global Impression (CGI), and World Health Organization Quality of Life-BREF (WHOQL-BREF) questionnaires at weeks 0, 4, and 8.</p></sec><sec id="sec0070"><title>Results</title><p>The intervention group showed clinical improvements in RAADS-R (P=0.010), social communication subscale of SRS (P=0.002), CGI (P=0.000), physical (P=0.004), psychological (P=0.006), and social relationships (P=0.046) domains of WHOQL-BREF. Improvements reached their maximum at week 4 and were maintained until week 8 (Table 1).<table-wrap position="anchor" id="tab1"><label>Table 1.</label><caption><p>Effect of group, time&#x000a0;time-group interaction and the effect size</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="3" valign="middle" rowspan="1">Time</th><th align="center" colspan="3" valign="middle" rowspan="1">Group</th><th align="center" colspan="3" valign="middle" rowspan="1">Time-Group Interaction</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">
F</th><th align="center" valign="middle" rowspan="1" colspan="1">
P-Value
</th><th align="center" valign="middle" rowspan="1" colspan="1">
Effect Size (Partial Eta Squared)</th><th align="center" valign="middle" rowspan="1" colspan="1">
F</th><th align="center" valign="middle" rowspan="1" colspan="1">
P-Value
</th><th align="center" valign="middle" rowspan="1" colspan="1">
Effect Size<break/>(Partial Eta Squared)</th><th align="center" valign="middle" rowspan="1" colspan="1">
F</th><th align="center" valign="middle" rowspan="1" colspan="1">
P-Value
</th><th align="center" valign="middle" rowspan="1" colspan="1">
Effect Size<break/>(Partial Eta Squared)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>AQ</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">19.44</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.000</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.344</td><td align="center" valign="middle" rowspan="1" colspan="1">0.391</td><td align="center" valign="middle" rowspan="1" colspan="1">0.536</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">2.63</td><td align="center" valign="middle" rowspan="1" colspan="1">0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">0.066</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>RAADS-R
</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.68</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.000</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.255</td><td align="center" valign="middle" rowspan="1" colspan="1">0.944</td><td align="center" valign="middle" rowspan="1" colspan="1">0.338</td><td align="center" valign="middle" rowspan="1" colspan="1">0.025</td><td align="center" valign="middle" rowspan="1" colspan="1">7.250</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.164</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>SRS</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">23.63</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.000</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.390</td><td align="center" valign="middle" rowspan="1" colspan="1">0.050</td><td align="center" valign="middle" rowspan="1" colspan="1">0.823</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">7.82</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.175</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>WHOQL-BREF -Physical Health</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.003</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.146</td><td align="center" valign="middle" rowspan="1" colspan="1">0.115</td><td align="center" valign="middle" rowspan="1" colspan="1">0.737</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">5.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.005</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.134</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>WHOQL-BREF -Psychological Health</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.31</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.183</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048</td><td align="center" valign="middle" rowspan="1" colspan="1">0.828</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">6.14</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.003</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.142</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>WHOQL-BREF -Social Relationships</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.72</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.173</td><td align="center" valign="middle" rowspan="1" colspan="1">1.052</td><td align="center" valign="middle" rowspan="1" colspan="1">0.312</td><td align="center" valign="middle" rowspan="1" colspan="1">0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">3.64</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.031</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.090</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>WHOQL-BREF -Environmental Health</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.87</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.010</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.116</td><td align="center" valign="middle" rowspan="1" colspan="1">0.162</td><td align="center" valign="middle" rowspan="1" colspan="1">0.690</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" rowspan="1" colspan="1">2.69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.074</td><td align="center" valign="middle" rowspan="1" colspan="1">0.068</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>CGI</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">22.08</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.000</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.374</td><td align="center" valign="middle" rowspan="1" colspan="1">2.28</td><td align="center" valign="middle" rowspan="1" colspan="1">0.139</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">9.42</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.203</td></tr></tbody></table><graphic xlink:href="S0924933824001512-TABU0001" position="anchor"/></alternatives><table-wrap-foot><p>AQ : Autism Spectrum Quotient, SRS : Social Responsiveness Scale, SCI : Social Communication Interaction, RRB : Restricted interest and repetitive behavior, WHOQL-BREF : World Health Organization Quality of life-BREF, CGI : Clinical Global Impression</p></table-wrap-foot></table-wrap></p></sec><sec id="sec0071"><title>Conclusions</title><p>The findings of this study suggest that nasal oxytocin therapy can significantly improve social skills and quality of life in individuals with ASD. Further research is needed to determine the timing and scope of oxytocin&#x02019;s effects across the lifespan.</p></sec><sec id="sec0072"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>